Breadcrumb
  1. Home
  2. Provider Relief
  3. About
  4. COVID-19 Coverage Assistance Fund

Due to the lapse in government funding, this website will not be updated. As a result, the information on this website may not be up to date, transactions submitted via the website may not be processed, and HRSA may not be able to respond to inquiries until appropriations are enacted. 

HRSA activities/events are cancelled or postponed unless you receive specific information to the contrary. Updates regarding government operating status and resumption of normal operations can be found at https://www.usa.gov(link is external)

COVID-19 Coverage Assistance Fund

About the program

HRSA provided claims reimbursement to eligible health care providers at the national Medicare rate for administering Food and Drug Administration (FDA) authorized COVID-19 vaccines under an Emergency Use Authorization or FDA-licensed COVID-19 vaccines under a Biologics License Application to underinsured individuals.

The CARES Act and its implementing regulations generally required most health plans to cover any qualifying coronavirus preventive service, including recommended COVID-19 vaccines and their administration, without imposing any cost-sharing requirements, such as a copayment for vaccine administration, co-insurance, or deductible.

Since providers administering COVID-19 vaccines were not permitted to bill patients directly to ensure they were fairly compensated for their efforts, the Coverage Assistance Fund (CAF) program was created to cover those costs that typically would have been the patient’s responsibility.

Vaccine administration fees for uninsured individuals were covered through HRSA’s Uninsured Program. The CAF extended the same level of support to providers who administered vaccines to underinsured individuals.

View the list of providers(link is external) who have received a reimbursement from the HRSA COVID-19 CAF program.

Date Last Reviewed: